Reticulate Pigmented Anomaly: Multimedia

References

1. Dowling GD, Freudenthal W. Acanthosis nigricans. Proc Roy Soc Med. 1938;31:1147-50.

2. Degos R, Ossipowski B. [Reticulated pigmentary dermatosis of the folds: relation to acanthosis nigricans.]. Ann Dermatol Syphiligr (Paris). Mar-Apr 1954;81(2):147-51. [Medline].

3. Schwartz RA, Birnkrant AP, Burgess GH, Stoll HL Jr, Yaqub M, Fox MD. Reticulate pigmented anomaly. Cutis. Oct 1980;26(4):380-1. [Medline].

4. Drut R, Pollono D, Drut RM. Bilateral nephroblastoma in familial Hay-Wells syndrome associated with familial reticulate pigmentation of the skin. Am J Med Genet. Jun 15 2002;110(2):164-9. [Medline].

5. Müller CS, Pföhler C, Tilgen W. Changing a concept--controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol. Jan 2009;36(1):44-8. [Medline].

6. El Shabrawi-Caelen L, Rütten A, Kerl H. The expanding spectrum of Galli-Galli disease. J Am Acad Dermatol. May 2007;56(5 Suppl):S86-91. [Medline].

7. Brown WG. Reticulate pigmented anomaly of the flexures. Case reports and genetic investigation. Arch Dermatol. Jul 1982;118(7):490-3. [Medline].

8. Li CR, Xing QH, Li M, et al. A gene locus responsible for reticulate pigmented anomaly of the flexures maps to chromosome 17p13.3. J Invest Dermatol. Jun 2006;126(6):1297-301. [Medline].

9. Betz RC, Planko L, Eigelshoven S, et al. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet. Mar 2006;78(3):510-9. [Medline].

10. Liao H, Zhao Y, Baty DU, McGrath JA, Mellerio JE, McLean WH. A heterozygous frameshift mutation in the V1 domain of keratin 5 in a family with Dowling-Degos disease. J Invest Dermatol. Feb 2007;127(2):298-300. [Medline].

11. Jones EW, Grice K. Reticulate pigmented anomaly of the flexures. Dowing Degos disease, a new genodermatosis. Arch Dermatol. Aug 1978;114(8):1150-7. [Medline].

12. Kim YC, Davis MD, Schanbacher CF, Su WP. Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases. J Am Acad Dermatol. Mar 1999;40(3):462-7. [Medline].

13. Zuo YG, Ho M, Jin HZ, Wang BX. Case report: a case of newborn onset reticulate pigmented anomaly of the flexures in a Chinese female. J Eur Acad Dermatol Venereol. Jul 2008;22(7):901-3. [Medline].

14. Sandhu K, Saraswat A, Kanwar AJ. Dowling-Degos disease with dyschromatosis universalis hereditaria-like pigmentation in a family. J Eur Acad Dermatol Venereol. Nov 2004;18(6):702-4. [Medline].

15. Loo WJ, Rytina E, Todd PM. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad. Clin Exp Dermatol. Nov 2004;29(6):622-4. [Medline].

16. O'Goshi K, Terui T, Tagami H. Dowling-Degos disease affecting the vulva. Acta Derm Venereol. May 2001;81(2):148. [Medline].

17. Massone C, Hofmann-Wellenhof R. Dermoscopy of Dowling-Degos disease of the vulva. Arch Dermatol. Mar 2008;144(3):417-8. [Medline].

18. Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol. Jul 1996;21(4):305-6. [Medline].

19. Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol. May 1991;24(5 Pt 2):888-92. [Medline].

20. Lee SJ, Lee HJ, Kim DW, Jun JB, Chung SL, Bae HI. A case of Dowling-Degos disease suggesting an evolutional sequence. J Dermatol. Sep 2000;27(9):591-7. [Medline].

21. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber's syndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. Jan 2009;160(1):215-7. [Medline].

22. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J Am Acad Dermatol. Nov 2001;45(5):760-3. [Medline].

23. Gilchrist H, Jackson S, Morse L, Nicotri T, Nesbitt LT. Galli-Galli disease: A case report with review of the literature. J Am Acad Dermatol. Feb 2008;58(2):299-302. [Medline].

24. Ee HL, Tan SH. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol. Mar 2005;30(2):131-3. [Medline].

25. Zhang RZ, Zhu WY. A study of immunohistochemical and electron microscopic changes in Dowling-Degos disease. J Dermatol. Jan 2005;32(1):12-8. [Medline].

26. Altomare G, Capella GL, Fracchiolla C, Frigerio E. Effectiveness of topical adapalene in Dowling-Degos disease. Dermatology. 1999;198(2):176-7. [Medline].

27. Boyle J, Burton JL. Reticulate pigmented anomaly of the flexures and seborrhoeic warts. Clin Exp Dermatol. Jul 1985;10(4):379-83. [Medline].

28. Kikuchi I. Evolution of Dowling Degos disease. J Dermatol. Dec 2000;27(12):806. [Medline].

29. Oiso N, Tsuruta D, Ota T, Kobayashi H, Kawada A. Spotted and rippled reticulate hypermelanosis: a possible variant of Dowling-Degos disease. Br J Dermatol. Jan 2007;156(1):196-8. [Medline].

30. Starzycki Z. [Case of reticulate pigmented anomaly of the flexures Dowling-Degos]. Przegl Dermatol. May-Jun 1981;68(3):383-7. [Medline].

31. Tappero JW, Kershenovich J, Berger TG. Combined acral and flexural reticulate pigmentary anomaly. Arch Dermatol. Oct 1992;128(10):1411-2. [Medline].

Further Reading

Keywords

reticulate pigmented anomaly, Dowling-Degos disease, dark dot disease, Dowling Degos Ossipowski disease, DDD

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Mark A Crowe, MD, Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine
Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Warren R Heymann, MD, Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey
Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.